Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.84 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8247 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.8221 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.8061 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD8435 |
Approved |
0.8 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7907 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7895 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7823 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7733 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7709 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7485 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7216 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7216 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7173 |
Intermediate Similarity |
NPD8462 |
Phase 1 |
0.7169 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD37 |
Approved |
0.7166 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7166 |
Intermediate Similarity |
NPD8319 |
Approved |
0.716 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.712 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7102 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7083 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7049 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.6994 |
Remote Similarity |
NPD6799 |
Approved |
0.698 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6979 |
Remote Similarity |
NPD7874 |
Approved |
0.6979 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD6784 |
Approved |
0.6944 |
Remote Similarity |
NPD6785 |
Approved |
0.6941 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6936 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6931 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD5494 |
Approved |
0.6913 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.691 |
Remote Similarity |
NPD6559 |
Discontinued |
0.691 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.691 |
Remote Similarity |
NPD7240 |
Approved |
0.6903 |
Remote Similarity |
NPD7095 |
Approved |
0.6897 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6872 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6862 |
Remote Similarity |
NPD6778 |
Approved |
0.6862 |
Remote Similarity |
NPD6782 |
Approved |
0.6862 |
Remote Similarity |
NPD6777 |
Approved |
0.6862 |
Remote Similarity |
NPD6781 |
Approved |
0.6862 |
Remote Similarity |
NPD6779 |
Approved |
0.6862 |
Remote Similarity |
NPD6776 |
Approved |
0.6862 |
Remote Similarity |
NPD6780 |
Approved |
0.686 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6852 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD7697 |
Approved |
0.6842 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD7698 |
Approved |
0.6842 |
Remote Similarity |
NPD3882 |
Suspended |
0.6839 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6832 |
Remote Similarity |
NPD5762 |
Approved |
0.6832 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6832 |
Remote Similarity |
NPD5763 |
Approved |
0.6828 |
Remote Similarity |
NPD7094 |
Approved |
0.6828 |
Remote Similarity |
NPD6858 |
Approved |
0.6824 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6816 |
Remote Similarity |
NPD7251 |
Discontinued |
0.681 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD3750 |
Approved |
0.6806 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6806 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6805 |
Remote Similarity |
NPD7411 |
Suspended |
0.6802 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD3226 |
Approved |
0.6783 |
Remote Similarity |
NPD2182 |
Approved |
0.6783 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.678 |
Remote Similarity |
NPD3818 |
Discontinued |
0.677 |
Remote Similarity |
NPD5405 |
Approved |
0.677 |
Remote Similarity |
NPD5406 |
Approved |
0.677 |
Remote Similarity |
NPD5408 |
Approved |
0.677 |
Remote Similarity |
NPD5404 |
Approved |
0.6769 |
Remote Similarity |
NPD7801 |
Approved |
0.6761 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.676 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6747 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6738 |
Remote Similarity |
NPD1237 |
Approved |
0.6736 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6728 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6728 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6725 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6709 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.6709 |
Remote Similarity |
NPD6663 |
Approved |
0.6709 |
Remote Similarity |
NPD7714 |
Approved |
0.6709 |
Remote Similarity |
NPD7715 |
Approved |
0.6708 |
Remote Similarity |
NPD3748 |
Approved |
0.6704 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6702 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6667 |
Remote Similarity |
NPD1930 |
Approved |
0.6667 |
Remote Similarity |
NPD1929 |
Approved |
0.6667 |
Remote Similarity |
NPD1934 |
Approved |
0.6667 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5736 |
Approved |
0.6667 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6648 |
Remote Similarity |
NPD7054 |
Approved |
0.6647 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD2534 |
Approved |
0.6647 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD2532 |
Approved |
0.6647 |
Remote Similarity |
NPD2533 |
Approved |
0.6646 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6634 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6625 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6614 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6611 |
Remote Similarity |
NPD7472 |
Approved |
0.6609 |
Remote Similarity |
NPD3749 |
Approved |
0.6607 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6605 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6604 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6601 |
Remote Similarity |
NPD4807 |
Approved |
0.6601 |
Remote Similarity |
NPD4806 |
Approved |
0.6582 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6581 |
Remote Similarity |
NPD5667 |
Approved |
0.6579 |
Remote Similarity |
NPD5305 |
Approved |
0.6579 |
Remote Similarity |
NPD5306 |
Approved |
0.6571 |
Remote Similarity |
NPD919 |
Approved |
0.6571 |
Remote Similarity |
NPD1238 |
Approved |
0.6564 |
Remote Similarity |
NPD2438 |
Suspended |
0.6562 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6561
|
Remote Similarity |
NPD5204 |
Approved |